Results 161 to 170 of about 2,075 (191)
Some of the next articles are maybe not open access.

Botulinum antitoxin

Reactions Weekly, 2021
openaire   +1 more source

DURATION OF PASSIVE IMMUNITY TO BOTULINUM TOXIN OFFERED BY ANTITOXIN IN MICE AND RABBITS

1965
Abstract : Various doses of botulinum antitoxin, types A and B, were administered to mice and rabbits by the intraperitoneal and intravenous routes. The persistence of a passive immunity to the type A toxin was determined by (1) administering challenge doses of the toxin at various times after the antitoxin and (2) determining the median lethal ratios (
Fred W. Oberst   +2 more
openaire   +1 more source

Botulinum-antitoxin

Reactions Weekly, 2022
openaire   +1 more source

Botulinum-antitoxin

Reactions Weekly, 2023
openaire   +1 more source

Investigation of the Prolonged Recovery Time Following Botulinum Intoxication. Efficacy of Intraperitoneal versus Intravenous Injection of Botulinum Antitoxin.

1973
Abstract : In order to study prolonged recovery times, mice were injected via the intramuscular route with sublethal concentrations of botulinum type A toxin. Proteolytic enzyme solutions were injected into the test site to determine if the removal of bound proteinacious toxin from neuromuscular junctions could influence paralytic recovery times ...
openaire   +1 more source

Botulinum-antitoxin

Reactions Weekly, 2020
openaire   +1 more source

Botulinum antitoxins and antibacterial IgM and IgG antibodies in sera of persons immunized with botulinum polytoxoid combined with cholera vaccine. I. Response to botulinum toxoid.

Archivum immunologiae et therapiae experimentalis, 1977
Two groups of subjects were immunized with combined vaccine containing aluminum hydroxide-adsorbed botulinum toxoids, types A, B, and E, and 4 mld of formaldehyde-inactivated V. cholerae Inaba and Ogawa organisms. The first group included laboratory workers who were previously immunized against cholera and had professional contact with botulinum toxins
A, Galazka   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy